{"gene":"SPTBN4","run_date":"2026-06-10T07:46:41","timeline":{"discoveries":[{"year":2022,"finding":"βIV-spectrin (SPTBN4) is required for voltage-gated sodium channel (Nav) clustering at the heminode along the nerve terminal in the auditory brainstem; loss of β4-spectrin in Sptbn4geo null mice impaired Nav clustering at the heminode (but not at nodes of Ranvier or axon initial segments), elevated action potential threshold, increased failure rates during high-frequency trains, and slowed central conduction, causing central auditory processing deficits.","method":"Presynaptic terminal electrophysiology, immunofluorescence/immunohistochemistry, auditory brainstem response recordings, and startle response assays in Sptbn4geo β4-spectrin null mice","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (electrophysiology, immunolocalization, behavioral) in a defined genetic null model with clear mechanistic readout","pmids":["35393465"],"is_preprint":false},{"year":2024,"finding":"β4-spectrin (encoded by SPTBN4) is not present in skeletal muscle; muscle-specific conditional knockout of β4-spectrin had no effect on muscle function or structure, demonstrating that the myopathy associated with pathogenic SPTBN4 variants is neurogenic rather than intrinsic to muscle.","method":"Muscle-specific conditional knockout mouse, muscle histology, muscle function assays, immunofluorescence for spectrin isoforms in skeletal muscle","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct conditional KO with multiple functional and histological readouts; mechanistically resolves the origin of SPTBN4-associated myopathy","pmids":["38441922"],"is_preprint":false},{"year":2021,"finding":"βIV-spectrin, together with ankyrin G, is responsible for clustering of KCNQ2/3-potassium channels and Nav-sodium channels at the axon initial segment and nodes of Ranvier; loss or reduction of βIV-spectrin destabilizes the cytoskeleton and impairs action potential generation, leading to neuronal degeneration. βIV-spectrin also maintains neuronal polarity and the diffusion barrier, and participates in cell signaling through binding of transcription factors.","method":"Clinical case report with whole-exome sequencing, review of existing functional literature on βIV-spectrin","journal":"Frontiers in neurology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — mechanistic claims are well-supported by existing literature cited in the abstract but the paper itself primarily reports a clinical case; mechanistic conclusions are based on prior work rather than new experiments in this paper","pmids":["33986717"],"is_preprint":false},{"year":2017,"finding":"Loss-of-function of βIV-spectrin (SPTBN4) in skeletal muscle results in absence of βIV-spectrin at the sarcolemma and causes fiber-type abnormalities: complete absence of type 1 fibers (fiber-type 2 uniformity) in quivering (qv4J) mice, and incomplete congenital fiber-type disproportion in the human patient. A homozygous nonsense mutation (p.Q533*) abolished the full-length 288 kDa isoform in muscle and a 72 kDa isoform in fibroblasts.","method":"Western blot, immunohistology of human and mouse muscle, autozygosity mapping and whole exome sequencing in patient, analysis of quivering mouse model","journal":"Human genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — protein expression confirmed by Western blot and immunohistology in both patient and animal model, but single lab with limited functional mechanistic depth","pmids":["28540413"],"is_preprint":false},{"year":2019,"finding":"A recessive 16-bp frameshift deletion in SPTBN4 produces a truncated β-spectrin non-erythrocytic 4 protein and causes postnatal mortality in pigs, with affected homozygous piglets displaying severe myopathy, hind-limb paralysis, tremors, and dispersed degeneration and decrease of cross-striations in dorsal and hind-limb muscle fibers.","method":"Whole-genome sequencing, SNP genotyping, histopathological examination of affected piglets","journal":"Frontiers in genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genomic identification of causal variant with histopathological validation in a natural knockout mammalian model","pmids":["31850074"],"is_preprint":false},{"year":2017,"finding":"Random transgene insertion into the mouse SPTBN4 locus greatly reduced βIV-spectrin protein expression in the brain and caused postnatal development of spastic paresis/paralysis in hind limbs, establishing βIV-spectrin as required for maintaining central motor pathway control; motor endplates remained fully innervated, localizing the defect to central pathways.","method":"Whole genome sequencing to map transgene insertion site, Western blotting for β-IV spectrin expression, longitudinal phenotypic assessment of L25 mouse line","journal":"Journal of neuromuscular diseases","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — transgene insertion mapped to SPTBN4 locus with protein reduction confirmed by Western blot and clear motor phenotype, but mechanism linking reduced spectrin to spasticity not molecularly resolved","pmids":["28582869"],"is_preprint":false},{"year":2022,"finding":"Tbx5 transcription factor represses SPTBN4 gene expression in cardiomyocytes; the p.D111Y Tbx5 variant failed to repress SPTBN4 (and CAMK2D), leading to increased βIV-spectrin and CaMKIIδ levels, which augmented the late component of Na+ current (INaL) and prolonged action potential duration in hiPSC-CMs and mouse cardiomyocytes.","method":"Transcriptional reporter assays, hiPSC-derived cardiomyocyte electrophysiology, mouse cardiomyocyte recordings from transgenic mice, pharmacological rescue with ranolazine","journal":"Cardiovascular research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (transcription assay, electrophysiology in hiPSC-CMs and mouse models, pharmacological rescue) but single lab","pmids":["33576403"],"is_preprint":false},{"year":2025,"finding":"GSK3 phosphorylation sites on βIV-spectrin were identified computationally and two sites were validated through in vitro phosphorylation assays; βIV-spectrin protein levels were reduced in neurons of the dorsolateral prefrontal cortex in schizophrenia postmortem samples, and sensitivity of βIV-spectrin distribution to AKT/GSK3 inhibitors was altered in iPSC-derived neurons from schizophrenia patients.","method":"Computational site prediction, in vitro kinase assays for GSK3 phosphorylation, postmortem immunofluorescence, iPSC-derived neuron imaging with AKT/GSK3 inhibitor treatment, Random Forest classifier","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro kinase assay validates GSK3 sites; iPSC and postmortem data are consistent but from single lab","pmids":["39920295"],"is_preprint":false},{"year":2013,"finding":"SPTBN4 (spectrin beta 4) at the axon initial segment undergoes DNA methylation-associated transcriptional silencing in Alzheimer's disease brain; hypermethylation of SPTBN4 was identified in two mouse models of Alzheimer's disease and confirmed in human patients with Alzheimer's disease.","method":"Genome-wide DNA methylation profiling of mouse brain regions and Alzheimer's disease mouse models; validation in human Alzheimer's disease patient samples","journal":"Brain : a journal of neurology","confidence":"Low","confidence_rationale":"Tier 3 / Moderate — identifies epigenetic silencing as a regulatory mechanism but no direct functional consequence of SPTBN4 methylation was experimentally tested","pmids":["24030951"],"is_preprint":false}],"current_model":"SPTBN4 encodes βIV-spectrin, a submembranous cytoskeletal protein that clusters voltage-gated Na+ channels (Nav) and KCNQ2/3 K+ channels at axon initial segments and nodes of Ranvier in neurons (in complex with ankyrin G), is required for Nav clustering at auditory brainstem heminodes and temporal fidelity of presynaptic spikes, is not present in skeletal muscle (so SPTBN4-associated myopathy is neurogenic), is transcriptionally repressed by TBX5 in cardiomyocytes (thereby modulating late Na+ current via CaMKIIδ), and is subject to GSK3-mediated phosphorylation; loss-of-function in mice and pigs causes spasticity, auditory processing deficits, and severe myopathy phenotypes consistent with human NEDHND disorder."},"narrative":{"mechanistic_narrative":"SPTBN4 encodes βIV-spectrin, a submembranous cytoskeletal scaffold that, in partnership with ankyrin G, clusters voltage-gated Na+ (Nav) channels and KCNQ2/3 K+ channels at the axon initial segment and nodes of Ranvier, thereby stabilizing the membrane cytoskeleton, maintaining neuronal polarity and the diffusion barrier, and enabling reliable action potential generation [PMID:33986717]. At specialized presynaptic sites in the auditory brainstem, βIV-spectrin is selectively required for Nav clustering at the heminode, and its loss raises action potential threshold, increases failure during high-frequency firing, and slows central conduction, producing central auditory processing deficits [PMID:35393465]. In vivo loss-of-function across mouse and pig models causes spastic paresis, tremor, and severe myopathy through disruption of central motor pathways rather than intrinsic muscle defects—muscle-specific knockout has no functional consequence because βIV-spectrin is absent from skeletal muscle, establishing the associated myopathy as neurogenic [PMID:38441922, PMID:28582869, PMID:31850074]. Beyond its structural role, βIV-spectrin expression is transcriptionally repressed by TBX5 in cardiomyocytes, and de-repression elevates βIV-spectrin and CaMKIIδ to augment the late Na+ current and prolong action potential duration [PMID:33576403]; the protein is also a substrate of GSK3 phosphorylation, with altered distribution in schizophrenia-derived neurons [PMID:39920295].","teleology":[{"year":2013,"claim":"Asked whether SPTBN4 expression is epigenetically regulated in neurodegenerative disease, establishing the gene as a target of DNA methylation in the brain.","evidence":"Genome-wide DNA methylation profiling in Alzheimer's mouse models with validation in human patient brain","pmids":["24030951"],"confidence":"Low","gaps":["No direct functional consequence of SPTBN4 hypermethylation was experimentally tested","Causal link between methylation and disease phenotype not established","No measurement of resulting βIV-spectrin protein change"]},{"year":2017,"claim":"Resolved whether reduced βIV-spectrin in the brain produces motor disease, localizing the defect to central pathways rather than the neuromuscular junction.","evidence":"Transgene-insertion mouse line with mapped SPTBN4 disruption, Western blot, and longitudinal motor phenotyping showing fully innervated endplates","pmids":["28582869"],"confidence":"Medium","gaps":["Molecular mechanism linking reduced spectrin to spasticity not resolved","Specific central circuit affected not identified"]},{"year":2017,"claim":"Connected SPTBN4 loss-of-function to muscle fiber-type pathology in human patient and quivering mouse, identifying a truncating mutation that abolishes the full-length isoform.","evidence":"Western blot and immunohistology of human and mouse muscle, autozygosity mapping and exome sequencing identifying p.Q533*","pmids":["28540413"],"confidence":"Medium","gaps":["Whether fiber-type changes are intrinsic to muscle or neurogenic was not resolved here","Mechanism connecting spectrin loss to fiber-type disproportion unclear"]},{"year":2019,"claim":"Confirmed in a natural mammalian knockout that SPTBN4 truncation causes severe myopathy and paralysis, extending the phenotype beyond mouse.","evidence":"Whole-genome sequencing identifying a frameshift deletion and histopathology of affected piglets","pmids":["31850074"],"confidence":"Medium","gaps":["Molecular pathway from protein truncation to muscle degeneration not defined","Did not distinguish neurogenic from myogenic origin"]},{"year":2021,"claim":"Synthesized the cytoskeletal scaffold model—βIV-spectrin with ankyrin G clusters Nav and KCNQ2/3 channels at the AIS and nodes and maintains neuronal polarity—framing how loss causes neuronal degeneration.","evidence":"Clinical case report with whole-exome sequencing combined with review of prior functional literature","pmids":["33986717"],"confidence":"Medium","gaps":["Mechanistic claims derive largely from prior literature rather than new experiments in this report","Direct biochemical demonstration of channel clustering not performed here"]},{"year":2022,"claim":"Demonstrated a site-specific requirement for βIV-spectrin in Nav clustering at the auditory heminode, linking the scaffold directly to presynaptic firing fidelity and central conduction.","evidence":"Presynaptic electrophysiology, immunolocalization, auditory brainstem responses, and startle assays in Sptbn4geo null mice","pmids":["35393465"],"confidence":"High","gaps":["Why heminodes are affected while nodes of Ranvier and AIS are spared not explained","Molecular determinants of heminode-specific clustering unknown"]},{"year":2024,"claim":"Definitively assigned SPTBN4-associated myopathy a neurogenic origin by showing βIV-spectrin is absent from skeletal muscle and muscle-specific knockout has no phenotype.","evidence":"Muscle-specific conditional knockout mouse with histology, function assays, and spectrin-isoform immunofluorescence","pmids":["38441922"],"confidence":"High","gaps":["The specific neuronal population whose dysfunction drives muscle pathology not pinpointed","Mechanism translating central neuronal defect to muscle change not detailed"]},{"year":null,"claim":"How βIV-spectrin selectively achieves channel clustering at distinct subcellular domains (heminode vs node vs AIS), and how its GSK3 phosphorylation and TBX5-mediated transcriptional control integrate into neuronal and cardiac physiology, remains unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No structural model of the βIV-spectrin/ankyrin G/channel complex in the timeline","Functional consequence of GSK3 phosphorylation sites not established in vivo","Direct binding partners beyond ankyrin G not biochemically mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[0,2]},{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[2]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,2,3]},{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,2]}],"complexes":[],"partners":["ANK3","KCNQ2","KCNQ3","TBX5","CAMK2D","GSK3"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9H254","full_name":"Spectrin beta chain, non-erythrocytic 4","aliases":["Beta-IV spectrin","Spectrin, non-erythroid beta chain 3"],"length_aa":2564,"mass_kda":289.0,"function":"","subcellular_location":"Cytoplasm, cytoskeleton; Cytoplasm, cell cortex","url":"https://www.uniprot.org/uniprotkb/Q9H254/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SPTBN4","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SPTBN4","total_profiled":1310},"omim":[{"mim_id":"617519","title":"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND","url":"https://www.omim.org/entry/617519"},{"mim_id":"611622","title":"IQ MOTIF-CONTAINING PROTEIN J; IQCJ","url":"https://www.omim.org/entry/611622"},{"mim_id":"606214","title":"SPECTRIN, BETA, NONERYTHROCYTIC, 4; SPTBN4","url":"https://www.omim.org/entry/606214"},{"mim_id":"605210","title":"DISC1 SCAFFOLD PROTEIN; DISC1","url":"https://www.omim.org/entry/605210"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoli","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":24.8},{"tissue":"pituitary gland","ntpm":7.4}],"url":"https://www.proteinatlas.org/search/SPTBN4"},"hgnc":{"alias_symbol":["SPTBN3","KIAA1642"],"prev_symbol":[]},"alphafold":{"accession":"Q9H254","domains":[{"cath_id":"1.10.418.10","chopping":"72-161","consensus_level":"medium","plddt":82.0291,"start":72,"end":161},{"cath_id":"1.10.418.10","chopping":"172-291","consensus_level":"medium","plddt":79.9703,"start":172,"end":291},{"cath_id":"1.20.58.60","chopping":"307-427","consensus_level":"medium","plddt":87.0383,"start":307,"end":427},{"cath_id":"1.20.58.60","chopping":"908-1113","consensus_level":"medium","plddt":75.751,"start":908,"end":1113},{"cath_id":"1.20.58.60","chopping":"1907-2059","consensus_level":"high","plddt":78.473,"start":1907,"end":2059},{"cath_id":"2.30.29.30","chopping":"2417-2535","consensus_level":"medium","plddt":83.1469,"start":2417,"end":2535}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H254","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H254-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9H254-F1-predicted_aligned_error_v6.png","plddt_mean":71.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SPTBN4","jax_strain_url":"https://www.jax.org/strain/search?query=SPTBN4"},"sequence":{"accession":"Q9H254","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9H254.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9H254/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9H254"}},"corpus_meta":[{"pmid":"28940097","id":"PMC_28940097","title":"Expanding the genetic heterogeneity of intellectual disability.","date":"2017","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28940097","citation_count":134,"is_preprint":false},{"pmid":"24030951","id":"PMC_24030951","title":"DNA methylation map of mouse and human brain identifies target genes in Alzheimer's disease.","date":"2013","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24030951","citation_count":116,"is_preprint":false},{"pmid":"31230720","id":"PMC_31230720","title":"The Genomics of Arthrogryposis, a Complex Trait: Candidate Genes and Further Evidence for Oligogenic Inheritance.","date":"2019","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31230720","citation_count":81,"is_preprint":false},{"pmid":"36697767","id":"PMC_36697767","title":"Spectrins: molecular organizers and targets of neurological disorders.","date":"2023","source":"Nature reviews. Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/36697767","citation_count":55,"is_preprint":false},{"pmid":"28540413","id":"PMC_28540413","title":"A recessive mutation in beta-IV-spectrin (SPTBN4) associates with congenital myopathy, neuropathy, and central deafness.","date":"2017","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28540413","citation_count":49,"is_preprint":false},{"pmid":"33576403","id":"PMC_33576403","title":"Tbx5 variants disrupt Nav1.5 function differently in patients diagnosed with Brugada or Long QT Syndrome.","date":"2022","source":"Cardiovascular research","url":"https://pubmed.ncbi.nlm.nih.gov/33576403","citation_count":26,"is_preprint":false},{"pmid":"33847457","id":"PMC_33847457","title":"Heterozygous variants in SPTBN1 cause intellectual disability and autism.","date":"2021","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/33847457","citation_count":22,"is_preprint":false},{"pmid":"29770609","id":"PMC_29770609","title":"Whole-exome sequencing for variant discovery in blepharospasm.","date":"2018","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29770609","citation_count":22,"is_preprint":false},{"pmid":"32411801","id":"PMC_32411801","title":"Genome-Wide Profiling of Human Papillomavirus DNA Integration into Human Genome and Its Influence on PD-L1 Expression in Chinese Uygur Cervical Cancer Women.","date":"2020","source":"Journal of immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/32411801","citation_count":20,"is_preprint":false},{"pmid":"34895032","id":"PMC_34895032","title":"Newborn differential DNA methylation and subcortical brain volumes as early signs of severe neurodevelopmental delay in a South African Birth Cohort Study.","date":"2022","source":"The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/34895032","citation_count":18,"is_preprint":false},{"pmid":"35782384","id":"PMC_35782384","title":"SPTBN5, Encoding the βV-Spectrin Protein, Leads to a Syndrome of Intellectual Disability, Developmental Delay, and Seizures.","date":"2022","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/35782384","citation_count":15,"is_preprint":false},{"pmid":"34588799","id":"PMC_34588799","title":"Applications of Machine Learning to Predict Cisplatin Resistance in Lung Cancer.","date":"2021","source":"International journal of general medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34588799","citation_count":15,"is_preprint":false},{"pmid":"29738887","id":"PMC_29738887","title":"Transcriptome analysis reveals enrichment of genes associated with auditory system in swimbladder of channel catfish.","date":"2018","source":"Comparative biochemistry and physiology. Part D, Genomics & proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/29738887","citation_count":11,"is_preprint":false},{"pmid":"31857255","id":"PMC_31857255","title":"A novel homozygous splice-site mutation in the SPTBN4 gene causes axonal neuropathy without intellectual disability.","date":"2019","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31857255","citation_count":9,"is_preprint":false},{"pmid":"31850074","id":"PMC_31850074","title":"Detection of a Frameshift Deletion in the SPTBN4 Gene Leads to Prevention of Severe Myopathy and Postnatal Mortality in Pigs.","date":"2019","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31850074","citation_count":9,"is_preprint":false},{"pmid":"38441922","id":"PMC_38441922","title":"Postsynaptic β1 spectrin maintains Na+ channels at the neuromuscular junction.","date":"2024","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/38441922","citation_count":9,"is_preprint":false},{"pmid":"35393465","id":"PMC_35393465","title":"Loss of β4-spectrin impairs Nav channel clustering at the heminode and temporal fidelity of presynaptic spikes in developing auditory brain.","date":"2022","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/35393465","citation_count":6,"is_preprint":false},{"pmid":"33986717","id":"PMC_33986717","title":"Severe Form of ßIV-Spectrin Deficiency With Mitochondrial Dysfunction and Cardiomyopathy-A Case Report.","date":"2021","source":"Frontiers in neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33986717","citation_count":5,"is_preprint":false},{"pmid":"40244264","id":"PMC_40244264","title":"Advancing Personalized Medicine in Alzheimer's Disease: Liquid Biopsy Epigenomics Unveil APOE ε4-Linked Methylation Signatures.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40244264","citation_count":4,"is_preprint":false},{"pmid":"40781329","id":"PMC_40781329","title":"Natural history of SPTBN4-related neurodevelopmental disorder with hypotonia, neuropathy, and deafness.","date":"2025","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/40781329","citation_count":3,"is_preprint":false},{"pmid":"39371122","id":"PMC_39371122","title":"Heterozygous loss-of-function variants in SPTAN1 cause a novel early childhood onset distal myopathy with chronic neurogenic features.","date":"2024","source":"medRxiv : the preprint server for health sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39371122","citation_count":3,"is_preprint":false},{"pmid":"39920295","id":"PMC_39920295","title":"βIV spectrin abundancy, cellular distribution and sensitivity to AKT/GSK3 regulation in schizophrenia.","date":"2025","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/39920295","citation_count":2,"is_preprint":false},{"pmid":"28582869","id":"PMC_28582869","title":"Postnatal Development of Spasticity Following Transgene Insertion in the Mouse βIV Spectrin Gene (SPTBN4).","date":"2017","source":"Journal of neuromuscular diseases","url":"https://pubmed.ncbi.nlm.nih.gov/28582869","citation_count":1,"is_preprint":false},{"pmid":"41819009","id":"PMC_41819009","title":"Clinical characterization of SPTBN1, SPTBN2, and SPTBN5 variants: A case series and systematic review.","date":"2026","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/41819009","citation_count":0,"is_preprint":false},{"pmid":"41613545","id":"PMC_41613545","title":"Study on the regulation mechanism of TBX5 gene and Gegen Qinlian decoction on colorectal cancer.","date":"2026","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/41613545","citation_count":0,"is_preprint":false},{"pmid":"41757252","id":"PMC_41757252","title":"Early pacing in a child with Lodder-Merla syndrome and progressive sinus node dysfunction: a case report.","date":"2026","source":"European heart journal. Case reports","url":"https://pubmed.ncbi.nlm.nih.gov/41757252","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":16363,"output_tokens":2546,"usd":0.043639,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9874,"output_tokens":2730,"usd":0.05881,"stage2_stop_reason":"end_turn"},"total_usd":0.102449,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2022,\n      \"finding\": \"βIV-spectrin (SPTBN4) is required for voltage-gated sodium channel (Nav) clustering at the heminode along the nerve terminal in the auditory brainstem; loss of β4-spectrin in Sptbn4geo null mice impaired Nav clustering at the heminode (but not at nodes of Ranvier or axon initial segments), elevated action potential threshold, increased failure rates during high-frequency trains, and slowed central conduction, causing central auditory processing deficits.\",\n      \"method\": \"Presynaptic terminal electrophysiology, immunofluorescence/immunohistochemistry, auditory brainstem response recordings, and startle response assays in Sptbn4geo β4-spectrin null mice\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (electrophysiology, immunolocalization, behavioral) in a defined genetic null model with clear mechanistic readout\",\n      \"pmids\": [\"35393465\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"β4-spectrin (encoded by SPTBN4) is not present in skeletal muscle; muscle-specific conditional knockout of β4-spectrin had no effect on muscle function or structure, demonstrating that the myopathy associated with pathogenic SPTBN4 variants is neurogenic rather than intrinsic to muscle.\",\n      \"method\": \"Muscle-specific conditional knockout mouse, muscle histology, muscle function assays, immunofluorescence for spectrin isoforms in skeletal muscle\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct conditional KO with multiple functional and histological readouts; mechanistically resolves the origin of SPTBN4-associated myopathy\",\n      \"pmids\": [\"38441922\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"βIV-spectrin, together with ankyrin G, is responsible for clustering of KCNQ2/3-potassium channels and Nav-sodium channels at the axon initial segment and nodes of Ranvier; loss or reduction of βIV-spectrin destabilizes the cytoskeleton and impairs action potential generation, leading to neuronal degeneration. βIV-spectrin also maintains neuronal polarity and the diffusion barrier, and participates in cell signaling through binding of transcription factors.\",\n      \"method\": \"Clinical case report with whole-exome sequencing, review of existing functional literature on βIV-spectrin\",\n      \"journal\": \"Frontiers in neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — mechanistic claims are well-supported by existing literature cited in the abstract but the paper itself primarily reports a clinical case; mechanistic conclusions are based on prior work rather than new experiments in this paper\",\n      \"pmids\": [\"33986717\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Loss-of-function of βIV-spectrin (SPTBN4) in skeletal muscle results in absence of βIV-spectrin at the sarcolemma and causes fiber-type abnormalities: complete absence of type 1 fibers (fiber-type 2 uniformity) in quivering (qv4J) mice, and incomplete congenital fiber-type disproportion in the human patient. A homozygous nonsense mutation (p.Q533*) abolished the full-length 288 kDa isoform in muscle and a 72 kDa isoform in fibroblasts.\",\n      \"method\": \"Western blot, immunohistology of human and mouse muscle, autozygosity mapping and whole exome sequencing in patient, analysis of quivering mouse model\",\n      \"journal\": \"Human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — protein expression confirmed by Western blot and immunohistology in both patient and animal model, but single lab with limited functional mechanistic depth\",\n      \"pmids\": [\"28540413\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A recessive 16-bp frameshift deletion in SPTBN4 produces a truncated β-spectrin non-erythrocytic 4 protein and causes postnatal mortality in pigs, with affected homozygous piglets displaying severe myopathy, hind-limb paralysis, tremors, and dispersed degeneration and decrease of cross-striations in dorsal and hind-limb muscle fibers.\",\n      \"method\": \"Whole-genome sequencing, SNP genotyping, histopathological examination of affected piglets\",\n      \"journal\": \"Frontiers in genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genomic identification of causal variant with histopathological validation in a natural knockout mammalian model\",\n      \"pmids\": [\"31850074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Random transgene insertion into the mouse SPTBN4 locus greatly reduced βIV-spectrin protein expression in the brain and caused postnatal development of spastic paresis/paralysis in hind limbs, establishing βIV-spectrin as required for maintaining central motor pathway control; motor endplates remained fully innervated, localizing the defect to central pathways.\",\n      \"method\": \"Whole genome sequencing to map transgene insertion site, Western blotting for β-IV spectrin expression, longitudinal phenotypic assessment of L25 mouse line\",\n      \"journal\": \"Journal of neuromuscular diseases\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — transgene insertion mapped to SPTBN4 locus with protein reduction confirmed by Western blot and clear motor phenotype, but mechanism linking reduced spectrin to spasticity not molecularly resolved\",\n      \"pmids\": [\"28582869\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Tbx5 transcription factor represses SPTBN4 gene expression in cardiomyocytes; the p.D111Y Tbx5 variant failed to repress SPTBN4 (and CAMK2D), leading to increased βIV-spectrin and CaMKIIδ levels, which augmented the late component of Na+ current (INaL) and prolonged action potential duration in hiPSC-CMs and mouse cardiomyocytes.\",\n      \"method\": \"Transcriptional reporter assays, hiPSC-derived cardiomyocyte electrophysiology, mouse cardiomyocyte recordings from transgenic mice, pharmacological rescue with ranolazine\",\n      \"journal\": \"Cardiovascular research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (transcription assay, electrophysiology in hiPSC-CMs and mouse models, pharmacological rescue) but single lab\",\n      \"pmids\": [\"33576403\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GSK3 phosphorylation sites on βIV-spectrin were identified computationally and two sites were validated through in vitro phosphorylation assays; βIV-spectrin protein levels were reduced in neurons of the dorsolateral prefrontal cortex in schizophrenia postmortem samples, and sensitivity of βIV-spectrin distribution to AKT/GSK3 inhibitors was altered in iPSC-derived neurons from schizophrenia patients.\",\n      \"method\": \"Computational site prediction, in vitro kinase assays for GSK3 phosphorylation, postmortem immunofluorescence, iPSC-derived neuron imaging with AKT/GSK3 inhibitor treatment, Random Forest classifier\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro kinase assay validates GSK3 sites; iPSC and postmortem data are consistent but from single lab\",\n      \"pmids\": [\"39920295\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SPTBN4 (spectrin beta 4) at the axon initial segment undergoes DNA methylation-associated transcriptional silencing in Alzheimer's disease brain; hypermethylation of SPTBN4 was identified in two mouse models of Alzheimer's disease and confirmed in human patients with Alzheimer's disease.\",\n      \"method\": \"Genome-wide DNA methylation profiling of mouse brain regions and Alzheimer's disease mouse models; validation in human Alzheimer's disease patient samples\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — identifies epigenetic silencing as a regulatory mechanism but no direct functional consequence of SPTBN4 methylation was experimentally tested\",\n      \"pmids\": [\"24030951\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SPTBN4 encodes βIV-spectrin, a submembranous cytoskeletal protein that clusters voltage-gated Na+ channels (Nav) and KCNQ2/3 K+ channels at axon initial segments and nodes of Ranvier in neurons (in complex with ankyrin G), is required for Nav clustering at auditory brainstem heminodes and temporal fidelity of presynaptic spikes, is not present in skeletal muscle (so SPTBN4-associated myopathy is neurogenic), is transcriptionally repressed by TBX5 in cardiomyocytes (thereby modulating late Na+ current via CaMKIIδ), and is subject to GSK3-mediated phosphorylation; loss-of-function in mice and pigs causes spasticity, auditory processing deficits, and severe myopathy phenotypes consistent with human NEDHND disorder.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SPTBN4 encodes βIV-spectrin, a submembranous cytoskeletal scaffold that, in partnership with ankyrin G, clusters voltage-gated Na+ (Nav) channels and KCNQ2/3 K+ channels at the axon initial segment and nodes of Ranvier, thereby stabilizing the membrane cytoskeleton, maintaining neuronal polarity and the diffusion barrier, and enabling reliable action potential generation [#2]. At specialized presynaptic sites in the auditory brainstem, βIV-spectrin is selectively required for Nav clustering at the heminode, and its loss raises action potential threshold, increases failure during high-frequency firing, and slows central conduction, producing central auditory processing deficits [#0]. In vivo loss-of-function across mouse and pig models causes spastic paresis, tremor, and severe myopathy through disruption of central motor pathways rather than intrinsic muscle defects—muscle-specific knockout has no functional consequence because βIV-spectrin is absent from skeletal muscle, establishing the associated myopathy as neurogenic [#1, #5, #4]. Beyond its structural role, βIV-spectrin expression is transcriptionally repressed by TBX5 in cardiomyocytes, and de-repression elevates βIV-spectrin and CaMKIIδ to augment the late Na+ current and prolong action potential duration [#6]; the protein is also a substrate of GSK3 phosphorylation, with altered distribution in schizophrenia-derived neurons [#7].\",\n  \"teleology\": [\n    {\n      \"year\": 2013,\n      \"claim\": \"Asked whether SPTBN4 expression is epigenetically regulated in neurodegenerative disease, establishing the gene as a target of DNA methylation in the brain.\",\n      \"evidence\": \"Genome-wide DNA methylation profiling in Alzheimer's mouse models with validation in human patient brain\",\n      \"pmids\": [\"24030951\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No direct functional consequence of SPTBN4 hypermethylation was experimentally tested\",\n        \"Causal link between methylation and disease phenotype not established\",\n        \"No measurement of resulting βIV-spectrin protein change\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Resolved whether reduced βIV-spectrin in the brain produces motor disease, localizing the defect to central pathways rather than the neuromuscular junction.\",\n      \"evidence\": \"Transgene-insertion mouse line with mapped SPTBN4 disruption, Western blot, and longitudinal motor phenotyping showing fully innervated endplates\",\n      \"pmids\": [\"28582869\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Molecular mechanism linking reduced spectrin to spasticity not resolved\",\n        \"Specific central circuit affected not identified\"\n      ]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Connected SPTBN4 loss-of-function to muscle fiber-type pathology in human patient and quivering mouse, identifying a truncating mutation that abolishes the full-length isoform.\",\n      \"evidence\": \"Western blot and immunohistology of human and mouse muscle, autozygosity mapping and exome sequencing identifying p.Q533*\",\n      \"pmids\": [\"28540413\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether fiber-type changes are intrinsic to muscle or neurogenic was not resolved here\",\n        \"Mechanism connecting spectrin loss to fiber-type disproportion unclear\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Confirmed in a natural mammalian knockout that SPTBN4 truncation causes severe myopathy and paralysis, extending the phenotype beyond mouse.\",\n      \"evidence\": \"Whole-genome sequencing identifying a frameshift deletion and histopathology of affected piglets\",\n      \"pmids\": [\"31850074\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Molecular pathway from protein truncation to muscle degeneration not defined\",\n        \"Did not distinguish neurogenic from myogenic origin\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Synthesized the cytoskeletal scaffold model—βIV-spectrin with ankyrin G clusters Nav and KCNQ2/3 channels at the AIS and nodes and maintains neuronal polarity—framing how loss causes neuronal degeneration.\",\n      \"evidence\": \"Clinical case report with whole-exome sequencing combined with review of prior functional literature\",\n      \"pmids\": [\"33986717\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanistic claims derive largely from prior literature rather than new experiments in this report\",\n        \"Direct biochemical demonstration of channel clustering not performed here\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstrated a site-specific requirement for βIV-spectrin in Nav clustering at the auditory heminode, linking the scaffold directly to presynaptic firing fidelity and central conduction.\",\n      \"evidence\": \"Presynaptic electrophysiology, immunolocalization, auditory brainstem responses, and startle assays in Sptbn4geo null mice\",\n      \"pmids\": [\"35393465\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Why heminodes are affected while nodes of Ranvier and AIS are spared not explained\",\n        \"Molecular determinants of heminode-specific clustering unknown\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Definitively assigned SPTBN4-associated myopathy a neurogenic origin by showing βIV-spectrin is absent from skeletal muscle and muscle-specific knockout has no phenotype.\",\n      \"evidence\": \"Muscle-specific conditional knockout mouse with histology, function assays, and spectrin-isoform immunofluorescence\",\n      \"pmids\": [\"38441922\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The specific neuronal population whose dysfunction drives muscle pathology not pinpointed\",\n        \"Mechanism translating central neuronal defect to muscle change not detailed\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How βIV-spectrin selectively achieves channel clustering at distinct subcellular domains (heminode vs node vs AIS), and how its GSK3 phosphorylation and TBX5-mediated transcriptional control integrate into neuronal and cardiac physiology, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No structural model of the βIV-spectrin/ankyrin G/channel complex in the timeline\",\n        \"Functional consequence of GSK3 phosphorylation sites not established in vivo\",\n        \"Direct binding partners beyond ankyrin G not biochemically mapped\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [0, 2]},\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 2, 3]},\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 2]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ANK3\", \"KCNQ2\", \"KCNQ3\", \"TBX5\", \"CAMK2D\", \"GSK3\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"faith_supported":4,"faith_total":4,"faith_pct":100.0}}